Sponsor:
UCLA
Code:
NCT05009992
Conditions
Diffuse Intrinsic Pontine Glioma
Diffuse Midline Glioma, H3 K27M-Mutant
Recurrent Diffuse Intrinsic Pontine Glioma
Recurrent Diffuse Midline Glioma, H3 K27M-Mutant
Recurrent WHO Grade III Glioma
Eligibility Criteria
Sex: All
Age: 2 - 39
Healthy Volunteers: Not accepted
Interventions
ONC201
Radiation Therapy
Paxalisib
DNX-2401
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-22. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2025-12-17.